Positioning early cell therapy programs for clinical success: Insights to mitigate risk and ensure GMP readiness

Webinar On Demand

Cell therapies have the potential to revolutionize treatment modalities for a wide range of conditions, from cardiovascular diseases to neurological disorders and many others. But their potential is often tempered by the myriad challenges of transitioning these innovations from R&D laboratories to real-world clinical applications.

Our recent webinar explored key considerations for early-phase cell therapy developers, including evolving regulatory guidelines and common manufacturing issues. Additionally, it covered the essentials of orchestrating a successful cell therapy clinical trial, showcasing the challenges and innovative solutions that today’s sponsors are likely to encounter.

In addition to these topics, specific webinar key takeaways included:

  • Opportunities for a more streamlined, patient-centric approach to cell therapy clinical trials
  • Strategies to navigate regulatory hurdles and maximize the impact of meetings with regulators
  • Best practices to address challenges in cell therapy process development and manufacturing
  • How an integrated CRO/CDMO can help simplify the value chain and improve patient centricity